C0013264||Duchenne Muscular Dystrophy
C0596995||Myoblasts
C0086418||Human
C2717959||iPSC
C0684309||Model
C0013264||Duchenne muscular dystrophy
C0013264||Duchenne muscular dystrophy
C0019247||genetic disease
C0012644||animal models
C0013264||Duchenne muscular dystrophy
C0682523||human cell
C1414083||DYSTROPHIN
C0596611||mutations
C0086418||human
C0013264||Duchenne muscular dystrophy
C0684309||model
C3658289||human induced pluripotent stem cells
C3658289||human induced pluripotent stem cells
C0012634||disease
C0220806||chemical-compound
C0035171||strategy
C3658289||human induced pluripotent stem cells
C0596995||myoblasts
C0040649||myogenic transcriptional
C1752744||contractile
C3179197||myofibers
C1850849||muscle regeneration
C1515655||in vivo
C0013264||Duchenne muscular dystrophy
C3658289||hiPSC
C0596995||myoblasts
C0012634||disease
C0021368||inflammation
C0086344||immune-response genes
C0009325||collagens
C1155364||BMP
C1155363||TGFÎ² signaling
C1571580||SMAD
C1519312||inhibition
C0013264||Duchenne muscular dystrophy
C3658289||hiPSC
C0596995||myoblasts
C0596995||myoblasts
C0242697||myotubes
C0086418||human
C0013264||Duchenne muscular dystrophy
C0684309||model
C3658289||hiPSC
C0684309||disease modeling